We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPT
501
Medical Properties Trust
MPT
$2.89B
| $489K | ﹤0.01% |
39,800
| – | – |
|
|
RAVN
502
DELISTED
Raven Industries Inc
RAVN
| $487K | ﹤0.01% |
19,350
-6,800
| -26% | -$162K |
|
503
Zoetis
ZTS
$31.6B
| $478K | ﹤0.01% |
8,940
+200
| +2% | +$10.2K |
|
504
Idexx Laboratories
IDXX
$42.9B
| $474K | ﹤0.01% |
4,050
+650
| +19% | +$74.2K |
|
505
Williams Companies
WMB
$90.5B
| $474K | ﹤0.01% |
15,234
-3,700
| -20% | -$112K |
|
506
Consolidated Edison
ED
$41.6B
| $471K | ﹤0.01% |
6,395
-742
| -10% | -$53.6K |
|
507
Amphenol
APH
$188B
| $470K | ﹤0.01% |
28,000
| – | – |
|
508
Packaging Corp of America
PKG
$22.7B
| $468K | ﹤0.01% |
5,529
-21
| -0.4% | -$1.76K |
|
509
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
| $454K | ﹤0.01% |
9,168
+8,198
| +845% | +$385K |
|
510
Unilever
UL
$131B
| $448K | ﹤0.01% |
9,796
-448
| -4% | -$20.9K |
|
|
B
511
Barrick Mining
B
$62.2B
| $444K | ﹤0.01% |
27,809
-10,430
| -27% | -$165K |
|
512
Nasdaq
NDAQ
$52.1B
| $444K | ﹤0.01% |
19,854
-1,350
| -6% | -$29.8K |
|
513
VanEck India Growth Leaders ETF
GLIN
$93.7M
| $443K | ﹤0.01% |
10,875
| – | – |
|
514
VanEck Gold Miners ETF
GDX
$23B
| $440K | ﹤0.01% |
21,066
| – | – |
|
|
SJT
515
San Juan Basin Royalty Trust
SJT
$117M
| $434K | ﹤0.01% |
65,671
-30,550
| -32% | -$192K |
|
516
Willis Towers Watson
WTW
$27.9B
| $425K | ﹤0.01% |
3,481
-603
| -15% | -$75.2K |
|
517
Global X Silver Miners ETF NEW
SIL
$4.08B
| $424K | ﹤0.01% |
13,230
-500
| -4% | -$18.5K |
|
|
ABB
518
DELISTED
ABB Ltd
ABB
| $424K | ﹤0.01% |
20,170
| – | – |
|
|
MOCO
519
DELISTED
Mocon Inc
MOCO
| $422K | ﹤0.01% |
21,647
| – | – |
|
520
Conagra Brands
CAG
$7.07B
| $421K | ﹤0.01% |
10,667
-1,771
| -14% | -$66.2K |
|
521
EQT Corp
EQT
$33.2B
| $421K | ﹤0.01% |
11,849
| – | – |
|
|
STI
522
DELISTED
SunTrust Banks, Inc.
STI
| $421K | ﹤0.01% |
7,688
| – | – |
|
|
PBCT
523
DELISTED
People's United Financial Inc
PBCT
| $417K | ﹤0.01% |
21,579
-14,518
| -40% | -$257K |
|
|
SIVB
524
DELISTED
SVB Financial Group
SIVB
| $416K | ﹤0.01% |
2,425
-575
| -19% | -$82.4K |
|
525
Brink's
BCO
$5.02B
| $415K | ﹤0.01% |
10,069
| – | – |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.